CY1107420T1 - Μεθοδος απενεργοποιησεως μικροοργανισμων - Google Patents
Μεθοδος απενεργοποιησεως μικροοργανισμωνInfo
- Publication number
- CY1107420T1 CY1107420T1 CY20081100448T CY081100448T CY1107420T1 CY 1107420 T1 CY1107420 T1 CY 1107420T1 CY 20081100448 T CY20081100448 T CY 20081100448T CY 081100448 T CY081100448 T CY 081100448T CY 1107420 T1 CY1107420 T1 CY 1107420T1
- Authority
- CY
- Cyprus
- Prior art keywords
- microorganism
- disability
- organizations
- micro
- inactivant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32161—Methods of inactivation or attenuation
- C12N2770/32163—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Fertilizers (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Η εφεύρεση αυτή δίδει μεθόδους απενεργοποιήσεως ενός μικροοργανισμού και παρασκευής ενός εμβολίου, οι οποίες περιλαμβάνουν το στάδιο χορηγήσεως εις τον αναφερθέντα μικροοργανισμό ενός παράγοντος δημιουργίας σταυροειδών δεσμών συγχρόνως με έναν ξεχωριστό παράγοντα απενεργοποιήσεως. Αυτή η εφεύρεση αφορά περαιτέρω εμβόλια που παρασκευάζονται από τέτοιες μεθόδους και ένα κιτίο το οποίο περιλαμβάνει έναν τέτοιο απενεργοποιημένο μικροοργανισμό. Ο παράγων δημιουργίας σταυροειδών δεσμών είναι συνήθως φορμαλδεϋδη (FA) και ο παράγων απενεργοποιήσεως συνήθως διμερής αιθυλενοϊμίνη (ΒΕΙ).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA997757 | 1999-12-20 | ||
EP00993526A EP1240310B1 (en) | 1999-12-20 | 2000-12-18 | Method of inactivating microorganisms |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107420T1 true CY1107420T1 (el) | 2012-12-19 |
Family
ID=25588046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100448T CY1107420T1 (el) | 1999-12-20 | 2008-04-22 | Μεθοδος απενεργοποιησεως μικροοργανισμων |
Country Status (14)
Country | Link |
---|---|
US (1) | US6673349B2 (el) |
EP (1) | EP1240310B1 (el) |
JP (1) | JP2003517834A (el) |
AT (1) | ATE384786T1 (el) |
AU (1) | AU782907B2 (el) |
BR (1) | BR0016563A (el) |
CA (1) | CA2394946C (el) |
CY (1) | CY1107420T1 (el) |
DE (1) | DE60037907T2 (el) |
DK (1) | DK1240310T3 (el) |
ES (1) | ES2300286T3 (el) |
PT (1) | PT1240310E (el) |
TR (1) | TR200202104T2 (el) |
WO (1) | WO2001046390A2 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4873632B2 (ja) * | 2004-01-21 | 2012-02-08 | メリアル リミテッド | 改良された不活化fcvワクチン |
EP2377885A4 (en) * | 2008-12-19 | 2012-07-04 | Saiwai Medix Kk | METHOD FOR PRODUCING GLOBAL ANTI-SURFACE ANTIBODY USING AS ANTIGEN A MICROORGANISM FIXED WITH PROTEIN CROSSLINKING FIXATION REAGENT |
WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
CN102406931B (zh) * | 2011-11-25 | 2014-02-05 | 成都康华生物制品有限公司 | 大流行流感病毒裂解疫苗 |
CN105056225B (zh) * | 2015-07-30 | 2018-01-16 | 成都天邦生物制品有限公司 | 一种灭活疫苗的制备方法 |
CA3010049C (en) * | 2016-01-15 | 2021-10-12 | The Chemo-Sero-Therapeutic Research Institute | Vaccine containing immobilized virus particles |
CN114540317A (zh) * | 2022-03-17 | 2022-05-27 | 新疆方牧生物科技有限公司 | 一种悬浮培养口蹄病毒灭活的工艺方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1924303A1 (de) * | 1969-05-13 | 1970-12-17 | Bayer Ag | AEthylaethylenimin als Inaktivierungsmittel |
US5069901A (en) * | 1988-02-03 | 1991-12-03 | Jones Elaine V | Preparation of a recombinant subunit vaccine against pseudorabies infection |
US5242686A (en) * | 1990-11-07 | 1993-09-07 | American Home Products Corporation | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
GB9110808D0 (en) * | 1991-05-17 | 1991-07-10 | Retroscreen Ltd | Aids vaccine and method for its production |
KR100374295B1 (ko) * | 1993-02-08 | 2003-12-24 | 바이엘 코포레이션 | 돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도 |
WO1997031093A1 (en) * | 1996-02-23 | 1997-08-28 | The Procter & Gamble Company | Disinfecting compositions |
-
2000
- 2000-12-18 AT AT00993526T patent/ATE384786T1/de active
- 2000-12-18 TR TR2002/02104T patent/TR200202104T2/xx unknown
- 2000-12-18 CA CA2394946A patent/CA2394946C/en not_active Expired - Fee Related
- 2000-12-18 JP JP2001546888A patent/JP2003517834A/ja active Pending
- 2000-12-18 AU AU29796/01A patent/AU782907B2/en not_active Ceased
- 2000-12-18 BR BR0016563-8A patent/BR0016563A/pt not_active IP Right Cessation
- 2000-12-18 DK DK00993526T patent/DK1240310T3/da active
- 2000-12-18 DE DE60037907T patent/DE60037907T2/de not_active Expired - Lifetime
- 2000-12-18 EP EP00993526A patent/EP1240310B1/en not_active Expired - Lifetime
- 2000-12-18 US US10/168,468 patent/US6673349B2/en not_active Expired - Fee Related
- 2000-12-18 ES ES00993526T patent/ES2300286T3/es not_active Expired - Lifetime
- 2000-12-18 PT PT00993526T patent/PT1240310E/pt unknown
- 2000-12-18 WO PCT/ZA2000/000254 patent/WO2001046390A2/en active IP Right Grant
-
2008
- 2008-04-22 CY CY20081100448T patent/CY1107420T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001046390A2 (en) | 2001-06-28 |
DK1240310T3 (da) | 2008-05-26 |
CA2394946A1 (en) | 2001-06-28 |
JP2003517834A (ja) | 2003-06-03 |
AU782907B2 (en) | 2005-09-08 |
EP1240310A2 (en) | 2002-09-18 |
BR0016563A (pt) | 2002-09-10 |
PT1240310E (pt) | 2008-05-05 |
CA2394946C (en) | 2010-12-14 |
DE60037907D1 (de) | 2008-03-13 |
TR200202104T2 (tr) | 2002-12-23 |
US6673349B2 (en) | 2004-01-06 |
ATE384786T1 (de) | 2008-02-15 |
AU2979601A (en) | 2001-07-03 |
DE60037907T2 (de) | 2009-07-09 |
US20030035811A1 (en) | 2003-02-20 |
WO2001046390A3 (en) | 2001-12-20 |
EP1240310B1 (en) | 2008-01-23 |
ES2300286T3 (es) | 2008-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107420T1 (el) | Μεθοδος απενεργοποιησεως μικροοργανισμων | |
AR055422A2 (es) | Composicion de antigeno, composicion de vacuna y procedimiento para tratar un cerdo | |
ES2186809T3 (es) | Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso. | |
ATE396739T1 (de) | Entwicklung einer vakzine zur prävention von infektionen mit filovirus bei primaten | |
ATE542829T1 (de) | Impfstoff | |
EA199900069A1 (ru) | Вакцинная композиция против малярии | |
ATE426412T1 (de) | Adjuvante influenza-vakzine | |
DE60226175D1 (de) | Mycobakterieller impfstoff | |
ES2089923T3 (es) | Composicion de vacuna subunitaria recombinante viva y procedimiento de preparacion. | |
ATE507286T1 (de) | Immunisierung von fischen gegen virusinfektion | |
HK1056830A1 (en) | Mannose as intranasal vaccine adjuvant | |
ATE213646T1 (de) | Grippe-impfstoff | |
ATE372129T1 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
EP1395283A4 (en) | HETEROLOGOUS PROTECTION INDUCED BY IMMUNIZATION WITH INVAPLEX VACCINE | |
NL300336I1 (nl) | Vaccin tegen de bof dat een jeryl-lynn virusstam bevat | |
NO20020615D0 (no) | Vaksine | |
DE59610629D1 (de) | Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine | |
ATE251121T1 (de) | Verfahren zur herstellung von 1,3,6- hexantricarbonitril | |
DK0544712T3 (da) | Neuraminidase og galactoseoxidase som vaccineadjuvans | |
AR027030A1 (es) | Metodo para la inactivacion de microorganismos | |
WO2003054176A3 (en) | Preparation of vaccines using photosensitizer and light | |
DE60036705D1 (de) | Adjuvanskombinationen zur immunisierung und vakzine | |
DE602004028512D1 (de) | Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon | |
DK0563288T3 (da) | Immunopotentiering af vacciner, navnlig svinepleuropneumoniavacciner |